You have 9 free searches left this month | for more free features.

Chronic Lymphocytic Leukaemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

Not yet recruiting
  • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
    • (no location specified)
    Dec 16, 2022

    Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom

    Recruiting
    • Chronic Lymphocytic Leukemia, CLL
    • Aylesbury, United Kingdom
    • +7 more
    Jan 12, 2023

    Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
    • Acalabrutinib capsule
    • Ahmedabad, India
    • +12 more
    Feb 2, 2023

    Retention Rate of Acalabrutinib in a Non-interventional Setting

    Recruiting
    • Chronic Lymphocytic Leukaemia (CLL)
      • Zittau, Germany
        Research Site
      Jan 12, 2023

      Pneumococcal Vaccination in Chronic Lymphocytic Leukaemia

      Recruiting
      • Pneumococcal Infections
      • +3 more
      • Prevnar13
      • Amsterdam-Zuidoost, Netherlands
        Amsterdam UMC Locatie AMC
      Dec 3, 2021

      Chronic Lymphocytic Leukemia, Minimal Residual Disease Trial in Bath (Exercise trial)

      Enrolling by invitation
      • Chronic Lymphocytic Leukemia
      • Minimal Residual Disease
      • Exercise trial
      • Bath, Bath & Northeast Somerset, United Kingdom
      • +1 more
      Oct 20, 2021

      Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in London (NVG-111, NVG-111 (RP2D))

      Recruiting
      • Chronic Lymphocytic Leukaemia
      • +2 more
      • London, United Kingdom
        University College London Hospital
      Jun 22, 2021

      Chronic Lymphocytic Leukemia Stage A(0), Chronic Lymphocytic Leukemia Stage A(I), Chronic Lymphocytic Leukemia Stage A(II) Trial

      Recruiting
      • Chronic Lymphocytic Leukemia Stage A(0)
      • +3 more
      • Low Dose Selenious Yeast Tablets
      • High Dose Selenious Yeast Tablets
      • Shanghai, Shanghai, China
        Zhongshan Hospital
      Nov 26, 2021

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

      Recruiting
      • Chronic Lymphocytic Leukemia
        • London, London, City Of, United Kingdom
        • +9 more
        Jan 13, 2023

        Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

        Active, not recruiting
        • Hodgkin's Lymphoma
        • +8 more
        • Reduced intensity haplodentical stem cell transplant
        • Myeloablative haploidentical stem cell transplant
        • Birmingham, United Kingdom
        • +11 more
        Sep 27, 2021

        Non Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia Trial in France, United Kingdom (Tirabrutinib)

        Completed
        • Non Hodgkins Lymphoma
        • Chronic Lymphocytic Leukaemia
        • Lille, France
        • +5 more
        Feb 22, 2021

        B-cell Lymphoma, Chronic Lymphocytic Leukaemia, Waldenström Macroglobulinemia Trial in United Kingdom (BI-1206 single agent dose

        Completed
        • B-cell Lymphoma
        • +2 more
        • BI-1206 single agent dose escalation phase
        • +3 more
        • Leicester, England, United Kingdom
        • +4 more
        Jun 17, 2021

        Leukemia, Lymphocytic, Chronic, B-Cell Trial in Belgium, France, Germany (BI 836826)

        Completed
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • BI 836826
        • Bruxelles, Belgium
        • +9 more
        Aug 10, 2020

        Study on the Diagnosis and Management of CLL in Italy by GIMEMA

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +2 more
          • Alessandria, Italy
          • +17 more
          Jan 3, 2022

          Chronic Lymphoid Leukaemia Observatory in Finistere Area, France

          Recruiting
          • Chronic Lymphoid Leukaemia
            • Brest, France
              CHRU de Brest
            Jan 27, 2021

            Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance

            Active, not recruiting
            • Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
              • Aichi, Japan
              • +48 more
              Dec 7, 2022

              Outcomes in Chronic Myeloid Leukaemia

              Completed
              • Chronic Myeloid Leukaemia
                • York, United Kingdom
                  Haematological Malignancy Research Network
                Jun 7, 2023

                Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

                Not yet recruiting
                • Chronic Lymphocytic Leukemia
                • Small Lymphocytic Lymphoma
                • (no location specified)
                Nov 22, 2023

                Chronic Lymphocytic Leukemia Patients

                Not yet recruiting
                • Chronic Lymphocytic Leukemia
                  • San Francisco, California
                    Power Life Sciences
                  Jun 2, 2023

                  Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

                  Not yet recruiting
                  • Chronic Lymphocytic Leukemia
                  • Loncastuximab Tesirine
                  • (no location specified)
                  Jul 24, 2023

                  Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

                  Not yet recruiting
                  • Chronic Lymphocytic Leukemia
                  • (no location specified)
                  Jul 10, 2023

                  Biomarker for Infection Risk in CLL and MM

                  Not yet recruiting
                  • Multiple Myeloma
                  • Chronic Lymphocytic Leukemia
                  • Screening
                  • Boston, Massachusetts
                    Massachusetts General Hospital Cancer Center
                  May 3, 2023

                  Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

                  Completed
                  • Multiple Myeloma
                  • Chronic Lymphocytic Leukemia
                  • Myeloma Coach or CLL Coach Mobile App
                  • Springboard Beyond Cancer informational website
                  • Durham, North Carolina
                    Duke University
                  Jun 23, 2023

                  Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

                  Recruiting
                  • Relapsed or Refractory CD19+ B-cell Lymphoma
                  • +2 more
                  • TBI-2001
                  • +2 more
                  • Toronto, Ontario, Canada
                    Princess Margaret Cancer Centre
                  Jul 26, 2023